## **Core Concept**
The question tests knowledge of specific cell surface markers (CD markers) used in immunophenotyping to differentiate between various hematopoietic cell lineages, particularly focusing on the myeloid series. CD markers are crucial in diagnosing and classifying hematological malignancies.

## **Why the Correct Answer is Right**
CD33 is a marker commonly associated with the myeloid lineage. It is a surface antigen that is expressed on the majority of immature and mature myeloid cells but not typically on lymphoid cells. This specificity makes CD33 a useful marker for identifying cells of the myeloid lineage, especially in the context of acute myeloid leukemia (AML).

## **Why Each Wrong Option is Incorrect**
- **Option A:** CD3 is a marker specific for T lymphocytes, not the myeloid series. It is part of the T-cell receptor (TCR) complex and plays a critical role in T-cell signaling.
- **Option B:** CD19 is a marker for B lymphocytes, expressed from the early stages of B-cell development until maturity. It is not specific to the myeloid series.
- **Option D:** CD56 is often associated with natural killer (NK) cells and a subset of T cells. While it can be expressed in some cases of acute myeloid leukemia (AML), particularly in the subtype known as acute myelomonocytic leukemia with eosinophilia (AMMe), it is not specific for the myeloid series.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that while CD33 is used as a marker for myeloid lineage, its expression can also be seen in some cases of acute lymphoblastic leukemia (ALL), particularly those with myeloid markers (MPO or CD13). However, for the purpose of this question and general specificity, CD33 is closely associated with myeloid cells.

## **Correct Answer:** . CD33